Novel diagnostic biomarkers discovery and validation for malaria and select neglected tropical diseases sbir phase I
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93025C00003
- Awardee
-
Kephera Diagnostics LLC UEI LJFNSE6NM648
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Contract value 100% obligated
- $300,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Framingham, MA 01702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Original award | $300,000 |
About this award
This is a $300,000.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Kephera Diagnostics LLC, a small business, for the discovery and validation of novel diagnostic biomarkers for malaria and select neglected tropical diseases. The contract is a Small Business Innovation Research (SBIR) Phase I award, meaning it supports early-stage research and development efforts. The work will be performed in Framingham, Massachusetts, and the contract has a completion date of May 1, 2025. Kephera Diagnostics is a for-profit limited liability company that specializes in developing innovative diagnostic solutions for infectious diseases, particularly neglected tropical diseases and parasitic infections. This contract award is part of the company's ongoing efforts to leverage federal funding to advance its research and development of specialized in vitro diagnostic tests and biomarker-based screening technologies to address critical global health challenges.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Northeastern University | $79,800 |
Quick answers
Who was awarded contract 75N93025C00003?
75N93025C00003 was awarded to Kephera Diagnostics LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 1, 2024.
How much is contract 75N93025C00003 worth?
The government has obligated $300,000 on 75N93025C00003.
Was contract 75N93025C00003 competed?
The extent of competition for 75N93025C00003 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award